Literature DB >> 7381723

Temporal variations in trough serum theophylline concentrations at steady state.

L J Lesko, D Brousseau, A T Canada, G Eastwood.   

Abstract

Temporal variations in serum theophylline concentrations were observed in 14 healthy volunteers receiving multiple doses of theophylline. After repeated oral doses (6.9--18.2 mg/kg/day) of theophylline as either a nonalcoholic aminophylline solution or a controlled-release capsule, trough theophylline levels at steady state were significantly higher (p less than 0.05) in the morning than in the afternoon or evening. With the solution, the mean (+/-SE) trough serum level at 7 am was 11.1 +/- 0.9 micrograms/ml, and at 1 pm it was 9.6 +/- 0.8 micrograms/ml. With the capsule, the mean (+/-SE) trough serum level at 8 am was 13.8 +/- 0.9 micrograms/ml, and at 8 pm it was 10.7 +/- 0.9 micrograms/ml. Temporal variations in serum theophylline concentrations have not been reported previously and may be important in therapeutic monitoring.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381723     DOI: 10.1002/jps.2600690332

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  27 in total

1.  Is diurnal variation in absorption of slow-release aminophylline an age-related phenomenon?

Authors:  A Rodgers; D N Bateman; K W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.

Authors:  H Chrystyn; J W Ellis; B A Mulley; M D Peake
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

3.  The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.

Authors:  H Lamont; R Pauwels; M Van der Straeten
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

4.  Diurnal variation in the pharmacokinetics of intravenous theophylline and etophylline in healthy subjects.

Authors:  B L Chauhan; B S Doshi; R D Kulkarni
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  A theophylline dosage regimen which reduces round-the-clock variations in plasma concentrations resulting from diurnal pharmacokinetic variation.

Authors:  M B Regazzi; R Rondanelli; E Vida; F Farinelli; R A Upton
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.

Authors:  S G Hibberd; C Alveyn; E J Coombes; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

Review 7.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

8.  Food induced changes in theophylline absorption from a once-a-day theophylline product.

Authors:  G Steffensen; S Pedersen
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

9.  Theophylline pharmacokinetics following single and repeated administration of slow-release capsules.

Authors:  J Torrent; I Izquierdo; M J Barbanoj; R Obach; M Nomen; F Jane
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

10.  Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.

Authors:  J H Jonkman; W J van der Boon; L P Balant; R Schoenmaker; A Holtkamp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.